Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business

IRVINE, Calif., Oct. 7, 2020 /PRNewswire/ — Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that it has entered into an agreement with Luminera, a privately held, aesthetics company based in Israel with a portfolio and pipeline of dermal filler products. 

Under the terms of the agreement, Allergan Aesthetics will acquire Luminera’s full dermal filler portfolio and R&D pipeline further enhancing Allergan Aesthetics’ leading dermal filler portfolio with its JUV DERM® collection of fillers. 

“The addition of the Luminera assets adds innovative technology, complementing our leading JUV DERM® filler franchise.  We welcome the Luminera team as we continue to build our global aesthetics company and a world-class product offering for healthcare professionals and patients around the world,” said Carrie Strom, SVP, AbbVie, and President, Global Allergan Aesthetics.

Luminera Chairman Dadi Segal, PhD, added, “We believe bringing together key, innovative Luminera assets with the support

Read More